BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10923944)

  • 1. Induction chemotherapy by superselective intra-arterial high-dose carboplatin infusion for head and neck cancer.
    Benazzo M; Caracciolo G; Zappoli F; Bernardo G; Mira E
    Eur Arch Otorhinolaryngol; 2000; 257(5):279-82. PubMed ID: 10923944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year results.
    Bertino G; Benazzo M; Gatti P; Bernardo G; Corbella F; Tinelli C; Zappoli F; Mira E
    BMC Cancer; 2007 Apr; 7():62. PubMed ID: 17428336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
    Grégoire V; Beauduin M; Humblet Y; Hamoir M; Longueville J; Majois F; Remacle FM; Rousseau F; Salamon E; Wambersie A
    J Clin Oncol; 1991 Aug; 9(8):1385-92. PubMed ID: 2072142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Wilson WR; Siegel RS; Harisiadis LA; Davis DO; Nguyen HH; Bank WO
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):809-12. PubMed ID: 11448355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers.
    Imai S; Kajihara Y; Munemori O; Kamei T; Mori T; Handa T; Akisada K; Orita Y
    Eur J Radiol; 1995 Dec; 21(2):94-9. PubMed ID: 8850500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
    Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
    Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The status of sequential chemo-/radiotherapy in inoperable head and neck cancers. Personal results and review of the literature].
    Volling P
    HNO; 1991 Jul; 39(7):254-9. PubMed ID: 1938489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
    Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superselective arterial infusion chemotherapy for squamous cell carcinomas of the oral cavity: histopathologic effects on metastatic neck lymph nodes.
    Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):269-75. PubMed ID: 17061084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results.
    Bertino G; Occhini A; Falco CE; Porta C; Corbella F; Colombo S; Balcet V; Morbini P; Zappoli F; Azzaretti A; Rodolico G; Tinelli C; Benazzo M
    BMC Cancer; 2009 Sep; 9():313. PubMed ID: 19732449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresectable primary and recurrent head and neck tumors: effect of hyperthermia and carboplatin--preliminary experience.
    Chang P; Sapozink MD; Grunberg SM; Jozsef G; Rice DM; Formenti SC; Streeter OE
    Radiology; 2000 Mar; 214(3):688-92. PubMed ID: 10715031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose-finding study for hyperfractionated, accelerated radiotherapy plus simultaneous carboplatin administration in patients with locoregionally advanced head and neck cancer].
    Kehrl W; Brockmann WP; Zschaber R; Hartwein J
    Laryngorhinootologie; 1992 Jul; 71(7):370-4. PubMed ID: 1497771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma.
    Taguchi T; Ikeda Y; Mikami Y; Kawai S; Arai Y; Mochimatsu I; Tsukuda M
    Anticancer Res; 2003; 23(1B):713-7. PubMed ID: 12680172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Conley BA; Egorin MJ; Levy S; Sivasailam S; Herman JM; Jacobs MC; Gray WC; Ord RA; Aisner JA; Van Echo DA
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):49-56. PubMed ID: 10758304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.